Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Enterprise Value: 2016-2025

Historic Enterprise Value for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to $816.4 million.

  • Collegium Pharmaceutical's Enterprise Value fell 27.42% to $816.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $233.7 million, marking a year-over-year increase of 4.08%. This contributed to the annual value of $761.2 million for FY2024, which is 9.81% up from last year.
  • Collegium Pharmaceutical's Enterprise Value amounted to $816.4 million in Q3 2025, which was up 12.10% from $728.3 million recorded in Q2 2025.
  • Collegium Pharmaceutical's Enterprise Value's 5-year high stood at $1.1 billion during Q3 2024, with a 5-year trough of $412.6 million in Q3 2022.
  • For the 3-year period, Collegium Pharmaceutical's Enterprise Value averaged around $728.0 million, with its median value being $742.1 million (2025).
  • As far as peak fluctuations go, Collegium Pharmaceutical's Enterprise Value spiked by 138.43% in 2024, and later decreased by 27.42% in 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Enterprise Value (Quarterly) stood at $459.3 million in 2021, then surged by 31.76% to $605.2 million in 2022, then climbed by 14.55% to $693.2 million in 2023, then increased by 9.81% to $761.2 million in 2024, then dropped by 27.42% to $816.4 million in 2025.
  • Its Enterprise Value was $816.4 million in Q3 2025, compared to $728.3 million in Q2 2025 and $742.1 million in Q1 2025.